Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Total 13F shares
-
5,334,098
-
Share change
-
+180,834
-
Total reported value
-
$94,763,968
-
Put/Call ratio
-
79%
-
Price per share
-
$17.75
-
Number of holders
-
65
-
Value change
-
+$2,751,020
-
Number of buys
-
33
-
Number of sells
-
34
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q3 2021
As of 30 Sep 2021,
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,334,098 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, GUARDIAN POINT CAPITAL, LP, FRED ALGER MANAGEMENT, LLC, Taylor Frigon Capital Management LLC, NORTHERN TRUST CORP, and Parian Global Management LP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.